Mushroom Conference

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

,
The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.
Women Are More Likely to Use Psychedelics Than Men

Survey: Women Use Psychedelics More Often Than Men

,
A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.
Australia to Study Psilocybin for Meth Addiction

Australia to Study Psilocybin for Meth Addiction

New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin.
Can Psilocybin Cure Obesity? NeonMind Biosciences Thinks It Just Might

Can Psilocybin Cure Obesity? NeonMind Biosciences Thinks It Just Might

Can psilocybin help cure obesity? NeonMind Biosciences is hopeful. The company is researching the benefits of psychedelics for eating disorders.
Psychotherapist Kelli Foulkrod Takes a Holistic Approach to Trauma Treatment With Psychedelics

Psychotherapist Kelli Foulkrod Takes a Holistic Approach to Trauma Treatment With Psychedelics

Psychotherapist Kelli Foulkrod uses psychedelics with her patients as part of her holistic treatment to mental health issues.
Ketamine Retreats Focus on Healing Power of Nature

Silo Wellness Ketamine Retreats to Focus on Healing Power of Nature

Silo Wellness Inc., a wellness company in the psychedelics and functional mushroom space, is offering ketamine-assisted psychedelics wellness retreats
Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression

Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression

Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.
Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin

Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin Mushrooms

,
The family of Bob Marley and Silo Wellness have teamed up for the first line of commercial psilocybin mushrooms.
Core One Labs and Ketamine Infusion Centers to Explore DMT Research for Anxiety and Depression

Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression

Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
Beckley Psychtech Explores Psilocybin for Headache Treatment

Beckley Psytech Explores Psilocybin for Headache Treatment

,
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.